The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography

Acta Diabetologica

Volumn 48, Issue 1, 2011, Pages 21-27

  Ertek, S ^a   Cicero, A F ^b   Cesur, M ^c   Akcil, M ^d   Kayhan, T Altuner ^c   Avcioglu, U ^c   Korkmaz, M E ^c  

^a UFUK UNIVERSITY   (Turkey)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c GÜVEN HOSPITAL   (Turkey)

^d BASKENT UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Coronary heart disease; Diabetes; Epidemiology; Metabolic syndrome

Indexed keywords

FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; TURKEY (REPUBLIC);

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 79953300284     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0211-7     Document Type: Article

References (42)

1. B Isomaa P Almgren T Tuomi B Forsén K Lahti M Nissén MR Taskinen L Groop 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683 689 11315831 10.2337/diacare.24.4.683 1:STN:280:DC%2BD3MvjsVOqsw%3D%3D (Pubitemid 32893993)
2. The IDF (2008) consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/webdata/docs/IDF-Metasyndrome-definition.pdf. Accessed 07 Dec 2008
3. KG Alberti PZ Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation Diabet Med 15 539 553 9686693 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 1:STN:280:DyaK1czkvFCrsA%3D%3D (Pubitemid 28319935)
4. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497
5. D Heng S Ma JJ Lee BC Tai KH Mak K Hughes SK Chew KS Chia CE Tan ES Tai 2006 Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease Atherosclerosis 186 367 373 16112123 10.1016/j.atherosclerosis.2005.07.020 1:CAS:528:DC%2BD28Xks1Wkurs%3D (Pubitemid 44269072)
6. N Sattar A McConnachie AG Shaper, et al. 2008 Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies Lancet 371 1927 1935 18501419 10.1016/S0140-6736(08)60602-9
7. DE Laaksonen HM Lakka LK Niskanen GA Kaplan JT Salonen TA Lakka 2002 Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study Am J Epidemiol 156 1070 1077 12446265 10.1093/aje/kwf145 (Pubitemid 35396938)
8. E Mannucci M Monami G Bardini A Ognibene CM Rotella 2007 National Cholesterol Education Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR study J Endocrinol Invest 30 925 930 18250613 1:STN:280:DC%2BD1c%2Fpt1WjtQ%3D%3D (Pubitemid 351350827)
9. G Assmann R Guerra G Fox P Cullen H Schulte D Willett SM Grundy 2007 Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the adult treatment panel III and International Diabetes Federation in United States American and European populations Am J Cardiol 99 541 548 17293200 10.1016/j.amjcard.2006.08.045 (Pubitemid 46215539)
10. CH Saely L Koch F Schmid, et al. 2006 Adult treatment panel III but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography Diabetes Care 29 901 907 16567835 10.2337/diacare.29.04.06.dc05-2011 (Pubitemid 44115314)
11. PJ Scanlon DP Faxon AM Audet, et al. 1999 ACC/AHA guidelines for coronary angiography: executive summary and recommendations: a report of American College of Cardiology/American Heart Association Task Force on clinical guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions Circulation 99 2345 2357 10226103 1:STN:280:DyaK1M3ksVKrtg%3D%3D
12. AV Chobanian GL Bakris HR Black, et al. 2003 National heart, lung, and blood institute joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560 2572 12748199 10.1001/jama.289.19.2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D (Pubitemid 37430158)
13. DM Nathan MB Davidson RA DeFronzo RJ Heine RR Henry R Pratley B Zinman 2007 Impaired fasting glucose and impaired glucose tolerance: implications for care Diabetes Care 30 753 759 17327355 10.2337/dc07-9920 1:CAS:528: DC%2BD2sXjs1GrurY%3D (Pubitemid 46354366)
14. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
15. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome- a new world-wide definition Lancet 366 1059 1062 16182882 10.1016/S0140-6736(05)67402-8 (Pubitemid 41338752)
16. SM Grundy JI Cleeman SR Daniels, et al. 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement Circulation 112 2735 2752 16157765 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
17. KM Anderson PW Wilson PM Odell WB Kannel 1991 An updated coronary risk profile: a statement for health professionals Circulation 83 356 362 1984895 1:STN:280:DyaK3M%2FosV2ktw%3D%3D
18. P Brindle J Emberson F Lampe M Walker P Whincup T Fahey S Ebrahim 2003 Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study BMJ 327 1267 14644971 10.1136/bmj.327.7426.1267
19. GG Gensini 1983 A more meaningful scoring system for determining the severity of coronary heart disease J Cardiol 51 606 611 10.1016/S0002-9149(83) 80105-2 1:STN:280:DyaL3s7itlyitw%3D%3D (Pubitemid 13187192)
20. Y Oishi T Wakatsuki A Nishikado T Oki S Ito 2000 Circulating adhesion molecules and severity of coronary atherosclerosis Coron Artery Dis 11 77 81 10715810 10.1097/00019501-200002000-00013 1:STN:280:DC%2BD3c7otVOjsg%3D%3D (Pubitemid 30142724)
21. The DECODA study group 2007 Prevalence of the metabolic syndrome in populations of the Asian origin: comparison of the IDF definition with the NCEP definition Diab Res Clin Pract 76 57 67 10.1016/j.diabres.2006.07.020 (Pubitemid 46240353)
22. J Liu SM Grundy W Wang, et al. 2006 Ethnic-specific criteria for the metabolic syndrome: evidence from China Diabetes Care 29 1414 1416 16732037 10.2337/dc06-0481 (Pubitemid 44125951)
23. AJ Hanley AJ Karter K Williams A Festa RB D'Agostino Jr LE Wagenknecht SM Haffner 2005 Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the insulin resistance atherosclerosis study Circulation 112 3713 3721 16344402 10.1161/CIRCULATIONAHA.105.559633 (Pubitemid 43739511)
24. W Rathmann B Haastert A Icks, et al. 2006 Prevalance of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA survey Diabetes Care 29 461 16443909 10.2337/diacare.29.02.06.dc05-1885 (Pubitemid 44106539)
25. DA Lawlor G Dawey Smith S Ebrahim 2006 Does the new International Diabetes Federation definition of metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's heart and health study Diabetologia 49 41 48 16378165 10.1007/s00125-005-0040-3 1:STN:280:DC%2BD28%2FltVGgtg%3D%3D (Pubitemid 43151612)
26. SP Tsai CP Wen HT Chan PH Chiang MK Tsai TY Cheng 2008 The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality Diabetes Res Clin Pract 82 148 156 18757109 10.1016/j.diabres.2008.07.016
27. I Protopsaltis G Nikolopoulos E Dimou P Brestas S Kokkoris P Korantzopoulos A Melidonis 2007 Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients Atherosclerosis 195 189 194 17064711 10.1016/j.atherosclerosis.2006.09. 019 1:CAS:528:DC%2BD2sXhtF2hurzP (Pubitemid 47561936)
28. PC Tong AP Kong WY So, et al. 2007 The usefulness of International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes Diabetes Care 30 1206 1211 17259472 10.2337/dc06-1484 (Pubitemid 46684649)
29. T Zornitzki O Ayzenberg G Gandelman, et al. 2007 Diabetes but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women QJM 100 575 581 17693419 10.1093/qjmed/hcm066 1:STN:280: DC%2BD2svovFehsA%3D%3D (Pubitemid 47317121)
30. T Kasai K Miyauchi N Kubota, et al. 2008 The relationship between metabolic syndrome defined by various criteria and the extent of coronary artery disease Atherosclerosis 197 944 950 18096168 10.1016/j.atherosclerosis.2007.08. 023 1:CAS:528:DC%2BD1cXktFCktbo%3D
31. A Nigam MG Bourassa A Fortier MC Guertin JC Tardif 2006 The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease Am Heart J 151 514 521 16442923 10.1016/j.ahj.2005.03.050 (Pubitemid 43144759)
32. B Yavuz G Kabakci H Aksoy, et al. 2008 Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease Int J Clin Pract 62 717 722 18266712 10.1111/j.1742-1241.2008.01702.x 1:STN:280:DC%2BD1c3ltFehtg%3D%3D (Pubitemid 351533669)
33. B Boden-Albala RL Sacco HS Lee, et al. 2008 Metabolic syndrome and ischemic stroke risk: Northern Manhattan study Stroke 39 30 35 18063821 10.1161/STROKEAHA.107.496588
34. H Yokoyama M Kuramitsu S Kanno J Tada Y Yokota F Kamikawa 2007 Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy Diab Res Clin Pract 75 200 206 10.1016/j.diabres.2006.06.015 1:STN:280:DC%2BD28jjsFamtg%3D%3D (Pubitemid 44894604)
35. Targuini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2010) The diabetic cardiomyopathy. Acta Diabetol. [Epub]
36. KM Pantalone MW Kattan C Yu, et al. 2009 The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin and sulfonylureas: a retrospective analysis Acta Diabetol 46 145 154 19194648 10.1007/s00592-008-0090-3 1:CAS:528:DC%2BD1MXlsFKlu7c%3D
37. AM Cerbone N Macarone-Palmieri G Saldalamacchia A Coppolla G Di Minno AA Rivellese 2009 Diabetes, vascular complications and antiplatelet therapy: open problems Acta Diabetol 46 253 261 19048181 10.1007/s00592-008-0079-y 1:CAS:528:DC%2BD1MXhtlKjt7rP
38. H Ogawa M Nakayama T Morimoto, et al. 2008 Low dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JAMA 300 2134 2141 18997198 10.1001/jama.2008.623 1:CAS:528:DC%2BD1cXhtlOrtLnM
39. A Onat K Ceyhan O Basar B Erer S Toprak V Sansoy 2002 Metabolic syndrome; major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation Atherosclerosis 165 285 292 12417279 10.1016/S0021-9150(02)00236-8 1:CAS:528:DC%2BD38Xotl2msb8%3D (Pubitemid 35339372)
40. Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome, A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung And Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
41. M Wallender K Malmberg A Norhammer L Rydén A Tenerz 2008 Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice Diabetes Care 31 36 38 10.2337/dc07-1552
42. OE Okosieme R Peter M Usman H Bolusani P Suruliram L George LM Evans 2008 Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome? Diabetes Care 31 1955 1959 18591399 10.2337/dc08-0197 1:CAS:528:DC%2BD1cXht1KksLfK